Logix Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 03-12-2024
- Paid Up Capital ₹ 0.10 M
as on 03-12-2024
- Company Age 16 Year, 8 Months
- Last Filing with ROC 31 Mar 2024
- Revenue 5.00%
(FY 2020)
- Profit 33.99%
(FY 2020)
- Ebitda 32.19%
(FY 2020)
- Net Worth 6.65%
(FY 2020)
- Total Assets 6.70%
(FY 2020)
About Logix Life Sciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sundaram Arulrhaj and Arulraj Aarathy serve as directors at the Company.
- CIN/LLPIN
U24230TN2008PTC067199
- Company No.
067199
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
03 Apr 2008
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Chennai
Industry
Company Details
- Location
Tuticorin, Tamil Nadu, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Logix Life Sciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sundaram Arulrhaj  | Director | 03-Apr-2008 | Current |
| Arulraj Aarathy | Director | 03-Apr-2008 | Current |
Financial Performance of Logix Life Sciences.
Logix Life Sciences Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 5% increase. The company also saw a substantial improvement in profitability, with a 33.99% increase in profit. The company's net worth moved up by a moderate rise of 6.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Logix Life Sciences?
In 2023, Logix Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sundaram Arulrhaj Health Care Private LimitedActive 29 years 8 monthsSundaram Arulrhaj and Arulraj Aarathy are mutual person
Commonwealth Medical Evarsity Private LimitedActive 9 years 19 daysSundaram Arulrhaj is a mutual person
- Aruls Energy And Environment Private LimitedActive 18 years 2 days
Sundaram Arulrhaj is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Logix Life Sciences?
Unlock and access historical data on people associated with Logix Life Sciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Logix Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Logix Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
